ZFIN ID: ZDB-EXP-160202-26
Experiment Conditions Description: chemical treatment: 2,4,6-trinitrobenzenesulfonic acid, chemical treatment: EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
chemical treatment: 2,4,6-trinitrobenzenesulfonic acid
Name: chemical treatment
Synonyms:
Definition: Experimental condition in which the fish is treated with a chemical substance. This treatment could be administered by adding the chemical substance to the tank water, injections, or by consumption.
Ontology: Zebrafish Environment Condition Ontology [ZECO:0000111]
Name: 2,4,6-trinitrobenzenesulfonic acid
Synonyms: 2,4,6-Trinitrobenzene-1-sulfonic acid, 2,4,6-Trinitrobenzenesulfonic acid, Picryl sulfonic acid, picrylsulfonic acid, TNBS, Trinitrobenzenesulfonic acid
Definition: The arenesulfonic acid that is benzenesulfonic acid with three nitro substituents in the 2-, 4- and 6-positions.
Ontology: ChEBI [CHEBI:53063]  ( EBI )
chemical treatment: EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
Name: chemical treatment
Synonyms:
Definition: Experimental condition in which the fish is treated with a chemical substance. This treatment could be administered by adding the chemical substance to the tank water, injections, or by consumption.
Ontology: Zebrafish Environment Condition Ontology [ZECO:0000111]
Name: EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
Synonyms: AATK inhibitor, AATYK inhibitor, AATYK2 inhibitor, AATYK3 inhibitor, ACH inhibitor, ALK inhibitor, ALK inhibitors, anaplastic lymphoma kinase inhibitor, anaplastic lymphoma kinase inhibitors, ARK inhibitor, ATP:[protein]-L-tyrosine O-phosphotransferase (receptor-type) inhibitor, ATP:[protein]-L-tyrosine O-phosphotransferase (receptor-type) inhibitors, AXL inhibitor, Bek inhibitor, Bfgfr inhibitor, BRT inhibitor, Bsk inhibitor, C-FMS inhibitor, CAK inhibitor, CCK4 inhibitor, CD115 inhibitor, CD135 inhibitor, CDw135 inhibitor, Cek1 inhibitor, Cek10 inhibitor, Cek11 inhibitor, Cek2 inhibitor, Cek3 inhibitor, Cek5 inhibitor, Cek6 inhibitor, Cek7 inhibitor, CFD1 inhibitor, CKIT inhibitor, CSF1R inhibitor, DAlk inhibitor, DDR1 inhibitor, DDR2 inhibitor, Dek inhibitor, DKFZp434C1418 inhibitor, Drosophila Eph kinase inhibitor, DRT inhibitor, DTK inhibitor, Ebk inhibitor, EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitors, EC 2.7.10.1 inhibitor, EC 2.7.10.1 inhibitors, ECK inhibitor, EDDR1 inhibitor, Eek inhibitor, EGFR inhibitor, Ehk2 inhibitor, Ehk3 inhibitor, Elk inhibitor, EPH inhibitor, EPHA1 inhibitor, EPHA2 inhibitor, EPHA6 inhibitor, EPHA7 inhibitor, EPHA8 inhibitor, EPHB1 inhibitor, EPHB2 inhibitor, EPHB3 inhibitor, EPHB4 inhibitor, EphB5 inhibitor, ephrin-B3 receptor tyrosine kinase inhibitor, EPHT inhibitor, EPHT2 inhibitor, EPHT3 inhibitor, EPHX inhibitor, ERBB inhibitor, ERBB1 inhibitor, ERBB2 inhibitor, ERBB3 inhibitor, ERBB4 inhibitor, ERK inhibitor, Eyk inhibitor, FGFR1 inhibitor, FGFR2 inhibitor, FGFR3 inhibitor, FGFR4 inhibitor, FLG inhibitor, FLK1 inhibitor, FLK2 inhibitor, FLT1 inhibitor, FLT2 inhibitor, FLT3 inhibitor, FLT4 inhibitor, FMS inhibitor, Fv2 inhibitor, HBGFR inhibitor, HEK11 inhibitor, HEK2 inhibitor, HEK3 inhibitor, HEK5 inhibitor, HEK6 inhibitor, HEP inhibitor, HER2 inhibitor, HER3 inhibitor, HER4 inhibitor, HGFR inhibitor, HSCR1 inhibitor, HTK inhibitor, IGF1R inhibitor, INSR inhibitor, INSRR inhibitor, insulin receptor protein-tyrosine kinase inhibitor, IR inhibitor, IRR inhibitor, JTK12 inhibitor, JTK13 inhibitor, JTK14 inhibitor, JWS inhibitor, K-SAM inhibitor, KDR inhibitor, KGFR inhibitor, KIA0641 inhibitor, KIAA1079 inhibitor, KIAA1459 inhibitor, Kil inhibitor, Kin15 inhibitor, Kin16 inhibitor, KIT inhibitor, KLG inhibitor, LTK inhibitor, MCF3 inhibitor, Mdk1 inhibitor, Mdk2 inhibitor, Mdk5 inhibitor, MEhk1 inhibitor, MEN2A/B inhibitor, Mep inhibitor, MER inhibitor, MERTK inhibitor, Mlk1 inhibitor, Mlk2 inhibitor, Mrk inhibitor, MST1R inhibitor, MTC1 inhibitor, MUSK inhibitor, Myk1 inhibitor, N-SAM inhibitor, NEP inhibitor, NET inhibitor, Neu inhibitor, neurite outgrowth regulating kinase inhibitor, NGL inhibitor, NOK inhibitor, nork inhibitor, novel oncogene with kinase-domain inhibitor, Nsk2 inhibitor, NTRK1 inhibitor, NTRK2 inhibitor, NTRK3 inhibitor, NTRK4 inhibitor, NTRKR1 inhibitor, NTRKR2 inhibitor, NTRKR3 inhibitor, Nuk inhibitor, NYK inhibitor, PCL inhibitor, PDGFR inhibitor, PDGFRA inhibitor, PDGFRB inhibitor, PHB6 inhibitor, PTK inhibitor, PTK3 inhibitor, PTK7 inhibitor, receptor protein tyrosine kinase inhibitor, receptor protein-tyrosine kinase (EC 2.7.10.1) inhibitor, receptor protein-tyrosine kinase (EC 2.7.10.1) inhibitors, receptor protein-tyrosine kinase inhibitor, receptor protein-tyrosine kinase inhibitors, RET inhibitor, RON inhibitor, ROR1 inhibitor, ROR2 inhibitor, ROS1 inhibitor, RSE inhibitor, RTK inhibitor, RYK inhibitor, SEA inhibitor, Sek2 inhibitor, Sek3 inhibitor, Sek4 inhibitor, Sfr inhibitor, SKY inhibitor, STK inhibitor, STK1 inhibitor, TEK inhibitor, TIE inhibitor, TIE1 inhibitor, TIE2 inhibitor, TIF inhibitor, TKT inhibitor, TRK inhibitor, TRKA inhibitor, TRKB inhibitor, TRKC inhibitor, TRKE inhibitor, TYK1 inhibitor, TYRO10 inhibitor, Tyro11 inhibitor, TYRO3 inhibitor, Tyro5 inhibitor, Tyro6 inhibitor, TYRO7 inhibitor, UFO inhibitor, VEGFR1 inhibitor, VEGFR2 inhibitor, VEGFR3 inhibitor, Vik inhibitor, YK1 inhibitor, Yrk inhibitor
Definition: An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1).
Ontology: ChEBI [CHEBI:62434]  ( EBI )
Publication: Okuda et al., 2015